At Atheris, we believe expertise is meant to be shared. Our network of scientists, strategists, and industry professionals publish insights on the trends, innovations, and challenges shaping the pharmaceutical and biotech landscape. Practical perspectives grounded in real-world experience.

More than 60% of oncology protocols are amended after activation, each costing 260-plus days. Where design decisions break down, and why de-risking them requires practicing-oncologist judgment accelerated by proprietary intelligence.

Dermatology is in the middle of a therapeutic revolution, but the evidence base is fragmenting faster than teams can track. Where the gaps are, why they persist, and how dermatology-specific AI is helping clinicians and medical affairs teams close them.

Biotech companies systematically ignore the FDA Fast Track pathway despite proven benefits, leaving millions in shareholder value and critical patient treatments unnecessarily delayed.
More articles coming soon; our team is continuously publishing new insights.
We’re always open to conversations. Let us know what’s on your mind.
Get in touch